Inflammation, fibrosis, cirrhosis and hepatocellular carcinoma (HCC) risk.
Glyco Liver Profile enables patient risk assessment, monitoring, diagnosis and 5-year prediction of hepatocellular carcinoma (HCC) development using four glycan biomarkers which together provide a clear insight into liver health.
The Glyco Liver Profile is a unique, non-invasive test that provides the clinician with a full picture of liver health regardless of aetiology — all from a single blood sample.
This innovative test addresses the medical and economic costs of chronic liver disease — accounting for approximately 2% of deaths annually — streamlining patient stratification and risk assessment, and improving clinical management and treatment outcomes.
Sign up below to learn about glycomics and how Glyco Liver Profile works.
Work with us to analyse and report the results of your patient samples.
Install V8 NEXUS in your laboratory to run your patient samples.
Glyco Liver Profile joins a range of existing tests running on our fully-automated V8 NEXUS capillary electrophoresis system.